KRAS and colorectal carcinoma: Sequence alterations in specific genes, including APC and KRAS, contribute to the development of early polypoid lesions, while other genetic aberrations, such as inactivating mutations of TP53, can promote malignancy and are observed in more advanced stages of CRC development [23].